Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China: a Multicenter, Ambispective, Observational, Open-cohort Study

NCT06869356 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06869356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06869356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China: a Multicenter, Ambispective, Observational, Open-cohort Study
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2018
Completion date
January 11, 2025
Enrollment
1,291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer stage